CoChat

Antiangiogenic immunotherapy suppresses desmoplastic and chemoresistant intestinal tumors in mice

Open access

The DOI matches its Crossref record; 81 of the 82 references it cites were found in a registry or an index.

Abstract

Mutations in APC promote colorectal cancer (CRC) progression through uncontrolled WNT signaling. Patients with desmoplastic CRC have a significantly worse prognosis and do not benefit from chemotherapy, but the mechanisms underlying the differential responses of APC-mutant CRCs to chemotherapy are not well understood. We report that expression of the transcription factor prospero homeobox 1 (PROX1) was reduced in desmoplastic APC-mutant human CRCs. In genetic Apc-mutant mouse models, loss of Prox1 promoted the growth of desmoplastic, angiogenic, and immunologically silent tumors through derepression of Mmp14. Although chemotherapy inhibited Prox1-proficient tumors, it promoted further stromal activation, angiogenesis, and invasion in Prox1-deficient tumors. Blockade of vascular endothelial growth factor A (VEGFA) and angiopoietin-2 (ANGPT2) combined with CD40 agonistic antibodies promoted antiangiogenic and immunostimulatory reprogramming of Prox1-deficient tumors, destroyed tumor fibrosis, and unleashed T cell-mediated killing of cancer cells. These results pinpoint the mechanistic basis of chemotherapy-induced hyperprogression and illustrate a therapeutic strategy for chemoresistant and desmoplastic CRCs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci129558

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 81 references

Cited by

See all 59

Metadata

Authors
Ragusa, S., Prat-Luri, B., González-Loyola, A., Nassiri, S., Squadrito, M. L., Guichard, A., Cavin, S., Gjorevski, N., Barras, D., Marra, G., Lutolf, M. P., Perentes, J., Corse, E., Bianchi, R., Wetterwald, L., Kim, J., Oliver, G., Delorenzi, M., De Palma, M., & Petrova, T. V.
Affiliations
  • Centre Hospitalier Universitaire Vaudois (CH)
  • SIB Swiss Institute of Bioinformatics (CH)
  • École Polytechnique Fédérale de Lausanne (CH)
  • University of Zurich (CH)
  • F. Hoffmann-La Roche AG (CH)
  • Northwestern University (US)
Corresponding author
Petrova, Tatiana V.
Venue
Journal of Clinical Investigation
Published
2020-02-04
Volume
130
Issue
3
Pages
1199-1216
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W3004730319
Cited by
56
References
82
Citations by year
2026: 2 · 2025: 9 · 2024: 10 · 2023: 9 · 2022: 11 · 2021: 11 · 2020: 4
FWCI
2.84
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
  • Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
  • IRIS (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • Swiss Cancer League (KLS 3406-02-2016, KFS-3759-08-2015)
  • MEDIC Foundation (Not available)
  • Fondation de lutte contre le cancer (N/A)
  • Roche (N/A)
  • Swiss Bridge Foundation (N/A)
  • N/A (N/A)
  • San Salvatore Foundation (N/A)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
colorectal cancer, desmoplasia, chemoresistance, Prox1, APC mutation, Wnt signaling, MMP-14, tumor stroma, angiopoietin-2, CD40 agonist, tumor fibrosis, T cell immunity, tumor angiogenesis
MeSH terms
Antineoplastic Agents, Immunological, Prospero-Related Homeobox 1 Protein, Animals, Cell Line, Humans, Immunotherapy, Neoplasms, Experimental, Neovascularization, Pathologic, Colorectal Neoplasms, Homeodomain Proteins, Drug Resistance, Neoplasm, Angiogenesis Inhibitors, Tumor Suppressor Proteins, Adenomatous Polyposis Coli Protein, Vascular Endothelial Growth Factor A, Angiopoietin-2, Mice, Matrix Metalloproteinase 14

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antiangiogenic immunotherapy suppresses desmoplastic and chemoresistant intestinal tumors in mice. https://app.cochat.ai/papers/10.1172/jci129558
The paper
Ragusa, S., Prat-Luri, B., González-Loyola, A., Nassiri, S., Squadrito, M. L., Guichard, A., Cavin, S., Gjorevski, N., Barras, D., Marra, G., Lutolf, M. P., Perentes, J., Corse, E., Bianchi, R., Wetterwald, L., Kim, J., Oliver, G., Delorenzi, M., De Palma, M., & Petrova, T. V. (2020). Antiangiogenic immunotherapy suppresses desmoplastic and chemoresistant intestinal tumors in mice. Journal of Clinical Investigation. https://doi.org/10.1172/jci129558

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.